How Fatal is Multiple Myeloma

In the world, Multiple myeloma (MM) is the second most commonly diagnosed blood cancer, after the non-Hodgkin lymphoma, yet few people know much about this deadly disease.

According to an article, in the year of 2013, approximately 21,990 Americans were diagnosed with Multiple Myeloma. And in the United States, data is about 73,910. At Global level, it’s estimated that 100,000 people were diagnosed with Multiple Myeloma in 2008, which equates to 12 percent of all blood cancers diagnosed, according to Cancer Research UK.

There are numerous patients around the world being diagnosed with multiple myeloma, and for some reason it’s being diagnosed in patients who are younger.”
The reason behind this hike is absolutely unspecified.
As we know that MM (Multiple Myeloma) is a cancer in which plasma cells (an important part of the immune system) become immortal and eventually replicate uncontrollably and accumulate in the existing bone marrow, the soft tissue at the center of the bones. The cancer cells grow out of control, crowding out normal cells.

As the disease progresses it can cause several effects, which may be responsible in order to specify MM, as fatal multiple Myeloma. Effects such as:

• A lack of RBC or sometimes even kidney failure. 
• Several people with MM experience debilitating bone pain and fractures that can be treated with the help of radiation or surgery. 
• Sometimes bone fractures may be particularly hazardous whenever they occur in the spinal column, causing the vertebrae to collapse or compress, damaging the spinal cord.
• In some cases, paralysis can occur.
• Patients can also feel adverse effects such as weight loss, numbness or weakness in the legs and repeated infections such as pneumonia, shingles or sinusitis.

In order to treat this fatal multiple myeloma, mainly a prescription medicine named Lenalidomide 25 mg can be useful as well as effective.
Lenalidomide capsules used in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation. 
Lenalidomide for Multiple Myeloma is a less toxic, oral cancer drug. 

Read:- Why is Pomalidomide useful in Multiple Myeloma Treatment?